Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Etoricoxib (60mg) + Paracetamol (325mg)
Therapeutic Category
Analgesics, Anti-Inflammatories, General and OTC medicines, Orthopedics, Rheumatology, Antipyretics
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10x10
Price
₹158/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Etoscrib P Tablet combines two active ingredients: Etoricoxib (60 mg) and Paracetamol (325 mg). This formulation is designed to provide effective relief from moderate to severe pain, making it particularly useful for conditions such as osteoarthritis, rheumatoid arthritis, and acute pain episodes. By targeting pain through dual mechanisms, Etoscrib P Tablet helps improve mobility and quality of life for individuals experiencing discomfort from inflammatory or musculoskeletal conditions.
Etoricoxib is a selective COX-2 inhibitor that reduces inflammation and alleviates pain while minimizing gastrointestinal side effects commonly associated with traditional nonsteroidal anti-inflammatory drugs (NSAIDs). Paracetamol complements this action by providing additional pain relief and reducing fever. This combination allows for a synergistic effect, ensuring that patients experience effective relief without the risk of increased gastrointestinal complications.
Potential side effects may include nausea, dizziness, headache, and gastrointestinal disturbances. In rare cases, serious allergic reactions or cardiovascular events may occur.
Etoscrib P Tablet is indicated for the management of moderate to severe pain, including pain associated with arthritis and acute pain episodes.
Consult a healthcare professional before use, especially if you have a history of heart disease, liver dysfunction, or gastrointestinal issues. In conclusion, Etoscrib P Tablet offers a robust solution for pain management by combining the analgesic properties of Paracetamol with the anti-inflammatory benefits of Etoricoxib. This unique formulation not only targets pain effectively but also prioritizes patient safety by reducing the likelihood of common NSAID-related side effects. Always follow prescribed dosages and consult with a healthcare provider for any concerns regarding this medication.
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
Composition : Etoricoxib (90mg) Tablet
Composition : Etoricoxib (60mg) Tablet
Composition : Etoricoxib (120mg)
Composition : Etodolac (600mg)
Composition : Etodolac (400mg) + Thiocolchicoside (4mg)
Composition : Piroxicam (20mg)
Composition : Nimesulide (100mg) MD Tablet
Composition : Drotaverine (80mg) + Mefenamic Acid (250mg)
Composition : Drotaverine (80mg) + Aceclofenac (100mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination is an anti-inflammatory + analgesic formulation used for pain, inflammation, and fever-related musculoskeletal conditions, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from steady demand in arthritis, osteoarthritis, dental pain, post-operative pain, back pain, and fever-associated body aches. It is commonly prescribed by orthopedicians, dentists, and general physicians for fast and effective pain relief.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Etoricoxib 60mg + Paracetamol 325mg Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from consistent prescription demand in orthopedic and general medicine segments, repeat usage in chronic pain patients, and strong acceptance in outpatient care when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this analgesic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.